Abstract
Nasopharyngeal cancer (NPC) with mastoid recurrence is extraordinarily rare, and its development is thought to involve the Eustachian tube. We herein report a case of NPC with mastoid recurrence masquerading as acute otomastoiditis with facial paralysis in a 60-year-old man 44 months after concurrent chemoradiotherapy. The diagnosis was confirmed by exploratory tympanomastoidectomy with biopsy and Epstein–Barr-encoding region (EBER) in situ hybridization. Distant liver metastasis was detected simultaneously, and the patient underwent salvage treatment. He died 15 months later. Despite the rarity of mastoid recurrence, clinicians should be vigilant in the differential diagnosis of mastoiditis in patients with NPC after radiotherapy. Tumor biopsy and EBER in situ hybridization can aid in the accurate diagnosis of this uncommon condition.
| Original language | English |
|---|---|
| Pages (from-to) | 754-757 |
| Number of pages | 4 |
| Journal | Auris Nasus Larynx |
| Volume | 44 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - Dec 2017 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Epstein–Barr-encoding region (EBER)
- In situ hybridization
- Mastoid recurrence
- Nasopharyngeal carcinoma (NPC)
- Otomastoiditis
ASJC Scopus subject areas
- Surgery
- Otorhinolaryngology
Fingerprint
Dive into the research topics of 'Nasopharyngeal carcinoma with mastoid recurrence after concurrent chemoradiotherapy masquerading as acute otomastoiditis'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS